Stockreport

Addex stock tanks after lead drug flops in Phase II epilepsy trial [Yahoo! Finance]

Cerevel Therapeutics Holdings, Inc.  (CERE) 
PDF Following the release of the Phase II top-line results, the Swiss company's stock was down by 53.3% at the market close on 29 April compared to the market close on the [Read more]